An official website of the United States government
PAR-21-293 - Clinical and Translational Science Award (UM1 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
| Title | Notice Number | Organization | Release Date | Expiration Date | Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Change in Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program PAR-21-337 (T32 Clinical Trial Not Allowed) | NOT-TR-22-037 | NCATS | Oct 14, 2022 | Mar 9, 2026 | UM1 |
| Notice of Availability for Applicants to Verify Funding Tier Calculation for CTSA Program Funding Opportunities: PAR-21-293 (UM1), PAR-21-336 (K12), PAR-21-338 (T32), and PAR-21-337 (T32) | NOT-TR-22-036 | NCATS | Oct 7, 2022 | Mar 9, 2026 | UM1 |
| Notice of Change in Eligibility for CTSA Program Funding Opportunities: PAR-21-336 (K12), PAR-21-339 (R25), PAR-21-338 (T32), and PAR-21-337 (T32) | NOT-TR-22-035 | NCATS | Oct 7, 2022 | Mar 9, 2026 | UM1 |
| Notice of Change to PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional) in Eligibility | NOT-TR-22-032 | NCATS | Jun 22, 2022 | Mar 9, 2026 | UM1 |
For technical issues E-mail OER Webmaster